Daud, Adil <br/><br/>
Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients.  [electronic resource] 

 -  Journal of hematology & oncology  01 2017 
 - 3 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-016-0369-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Azetidines--administration & dosage<br/>Female<br/>Humans<br/>Imidazoles--administration & dosage<br/>Indoles--administration & dosage<br/>Male<br/>Melanoma--complications<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Oximes--administration & dosage<br/>Piperidines--administration & dosage<br/>Pyridones--administration & dosage<br/>Pyrimidinones--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Vemurafenib<br/>Young Adult